Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-25-053765
Filing Date
2025-04-14
Accepted
2025-04-14 17:00:10
Documents
11
Period of Report
2025-04-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A eldn-20250401.htm   iXBRL 8-K/A 51924
  Complete submission text file 0000950170-25-053765.txt   169795

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20250401.xsd EX-101.SCH 25775
13 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20250401_htm.xml XML 4844
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36620 | Film No.: 25836621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)